wanabby
☆    

2012-03-08 05:52
(5226 d 12:15 ago)

Posting: # 8231
Views: 1,545
 

 same drug substance, 2 brands with different strengths [Regulatives / Guidelines]

Dear all,

This is my first post and I did a search before posting. the similar topic with my question is (http://forum.bebac.at/mix_entry.php?id=6772#p6772),but mine is absolutely not the same.

Get down to the business,I have a problem, we would like to submit a ANDA in Germany, but the RLD (R) has 4 strengths, and the lowest stength(R1) has a different brand name(AOO) with the other 3 Strengths (AOB). If the dissolution of AOO is different with AOB.

Whether we should conduct 2 BE studies with the lowest strength and the highest strength?
and if we can make our the dissolution of our 4 preparations the same, can we only conduct one BE Study with the highest strength?

Can anyone give some reference/guideline to me in detail? Thanks a million.

Abby
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
278 visitors (0 registered, 278 guests [including 18 identified bots]).
Forum time: 19:07 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5